Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options (2020) Merola E, Prasad V, Pascher A, Pape UF, Arsenic R, Denecke T, Fehrenbach U, et al. Journal article Inherited CDH1 pathogenic variant: is there a place for surveillance of esophageal gastric inlet patch? (2020) Leclercq P, Jadot V, Bours V, Oliveira C, Neumann H, Bisschops R Journal article Covid-19 and immunomodulation in IBD (2020) Neurath M Journal article, Review article COVID-19: risk for cytokine targeting in chronic inflammatory diseases? (2020) Schett G, Sticherling M, Neurath M Journal article The first real-life multicentre prospective validation study of the electronic chromoendoscopy score (Paddington International Virtual ChromoendoScopy ScOre) and its outcome in ulcerative colitis (2020) Iacucci M, Smith SC, Bazarova A, Shivaji UN, Bhandari P, Cannatelli R, Daperno M, et al. Conference contribution Effectiveness of vedolizumab therapy in a real-world setting in Germany: First results of the VEDOibd study comparing vedolizumab to the use of other biologics (2020) Bokemeyer B, Plachta-Danielzik S, Sobotzki C, Mohl W, Hoffstadt M, Krause T, Atreya R, et al. Conference contribution An IFN-STAT1-MLKL axis drives programmed necrosis of Paneth cells in Crohn's ileitis (2020) Hartmann L, Siegmund B, Weidinger C, Becker C, Neurath M, Günther C Conference contribution Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution Dose-dependent differential effects of vedolizumab therapy on adhesion of regulatory and effector T cells (2020) Becker E, Wiendl M, Schulz-Kuhnt A, Atreya I, Atreya R, Neurath M, Zundler S Conference contribution Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase (2020) Kremer A, Bausenwein J, Lurvink E, Kremer A, Rutten CE, van Bergen CA, Kretschmann S, et al. Journal article